Kiniksa Pharmaceuticals
KNSA
KNSA
131 hedge funds and large institutions have $659M invested in Kiniksa Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 53 increasing their positions, 45 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
14% less capital invested
Capital invested by funds: $768M → $659M (-$109M)
15% less funds holding
Funds holding: 154 → 131 (-23)
52% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 42
Holders
131
Holding in Top 10
3
Calls
$1.34M
Puts
$1.25M
Top Buyers
| 1 | +$13.3M | |
| 2 | +$12.4M | |
| 3 | +$7.42M | |
| 4 |
Millennium Management
New York
|
+$7.14M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$4.17M |
Top Sellers
| 1 | -$58.8M | |
| 2 | -$15M | |
| 3 | -$8.79M | |
| 4 |
Citigroup
New York
|
-$3.42M |
| 5 |
Pictet Asset Management
Carouge,
Switzerland
|
-$2.93M |